Skip to main content

Month: July 2024

Fortrea Appoints Robert Parks as Chief Accounting Officer

DURHAM, N.C., July 11, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Robert “Bobby” Parks has been appointed as chief accounting officer (CAO), responsible for Fortrea’s accounting function, including financial reporting, risk, controls and compliance in accordance with applicable standards, laws and regulations. “We are pleased to welcome Bobby to the Fortrea team, bringing his broad and deep experience from CROs and other fast-paced environments,” said Fortrea Chief Financial Officer Jill McConnell. “Bobby has a track record of managing Sarbanes-Oxley Act requirements and internal controls, including for CROs, in a public-company setting. He is a strategic thinker who understands our customers and our business priorities. I look forward to Bobby making...

Continue reading

Northern Technologies International Corporation Reports Financial Results for Third Quarter Fiscal 2024

MINNEAPOLIS, July 11, 2024 (GLOBE NEWSWIRE) — Northern Technologies International Corporation (NASDAQ: NTIC), a leading developer of corrosion inhibiting products and services, as well as bio-based and biodegradable polymer resin compounds, today reported its financial results for the third quarter of fiscal 2024. Third quarter fiscal 2024 financial and operating highlights include (with growth rates on a fiscal quarter year-over-year basis):Consolidated net sales decreased 1.4% to $20,686,000 ZERUST® industrial net sales decreased 4.4% to $13,477,000 ZERUST® oil and gas net sales decreased 31.9% to $1,360,000 – the year-over-year decline was primarily due to the timing of approximately $600,000 of orders that moved from the third quarter of fiscal 2024 to the fourth quarter of fiscal 2024 Natur-Tec® product net sales increased...

Continue reading

STRATA Skin Sciences Pre-Announces Second Quarter 2024 Financial Results

HORSHAM, Penn., July 11, 2024 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces preliminary total revenue in the range of $8.0 million – $8.4 million for the second quarter of 2024. Consistent with the Company’s stated plans of realigning its devices and removing them from underperforming account, the domestic installed base of XTRAC® devices declined from 907 at the end of the first quarter of 2024 to 881 at the end of the second quarter of 2024. The domestic installed base of TheraClear®X devices continued to grow, rising from 104 at the end of the first quarter of 2024 to 117 at the end of the second quarter of 2024. Cash,...

Continue reading

Latin Metals Reports AGM Results

Appoints New Independent Director and Grants Incentive Stock Options VANCOUVER, British Columbia, July 11, 2024 (GLOBE NEWSWIRE) — Latin Metals Inc. (“Latin Metals” or the “Company”) – (TSXV: LMS) (OTCQB: LMSQF) reports the results of its annual general meeting (the “Meeting”) of shareholders held on July 10, 2024, in Vancouver, British Columbia. All the motions presented to the shareholders were approved. Votes representing 48,668,109 shares were cast, representing 59.73% of the issued and outstanding shares at the record date. A summary of the voting results is outlined below:Motion Votes for the Motion Percentage of Votes in FavourNumber of Directors 48,668,109 100%David Cass 48,667,422 100%Keith Henderson 48,667,422 100%Robert Kopple 48,667,422 100%Appointment of Auditor 48,668,109 100%Ratification...

Continue reading

Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds

CINCINNATI, Ohio, July 11, 2024 (GLOBE NEWSWIRE) — Onconetix, Inc. (“Onconetix” or the “Company”) (Nasdaq: ONCO), today announced it has entered into definitive agreements for the immediate exercise of certain existing warrants to purchase 7,458,642 shares of its common stock originally issued in August 2022 and August 2023, having exercise prices ranging from $1.09 to $2.546 per share, at a reduced exercise price of $0.15 per share. The transaction is expected to close on or about July 12, 2024, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the transaction. The aggregate gross proceeds from the exercise of the existing warrants are expected to be approximately $1.11 million, before deducting placement agent fees and other offering expenses payable...

Continue reading

MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets

DALLAS, TEXAS, July 11, 2024 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the areas of erectile dysfunction (ED), hair growth, weight loss, and hormone replacement therapies, is excited to announce that it has secured a strategic partnership with the International Society of Frontier Life Sciences and Technology (ISFLST) for the distribution of its products in China and the Asia Pacific region and Latin America (excluding Mexico). This agreement marks a significant milestone in MangoRx’s expansion strategy, aiming to bring its premier men’s health solutions to the rapidly growing markets in these regions. Under this agreement, ISFLST, who has offices in the US,...

Continue reading

Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing

VANCOUVER, British Columbia, July 11, 2024 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) reports that early testing by Omega Laboratories Inc (“Omega Laboratories” or “Omega”) with the Company’s marijuana breathalyzer technology have garnered positive results. Omega has commenced pre-validation scoping work to establish limits of detection (LOD) and limits of quantification (LOQ) as well as the cutoff level for the detection of delta-9 THC (primary psychoactive ingredient in cannabis) in breath. Recently, Cannabix entered into a strategic partnership and development agreement with Omega Laboratories to advance the development and commercialization of the Cannabix marijuana breathalyzer technology. Omega Laboratories is an international industry leader in...

Continue reading

Rectitude Celebrates Completion of Initial Public Offering with Nasdaq Bell Ringing Ceremony

Rectitude Bell Ringing Ceremony PictureRectitude Executive TeamSINGAPORE, July 11, 2024 (GLOBE NEWSWIRE) — Rectitude Holdings Ltd. (Nasdaq: RECT; the “Company” or “Rectitude”), a Singapore-based provider of safety equipment and related industrial products, today announced that its management team participated in a Nasdaq Bell Ringing Ceremony at Capella Singapore. Nasdaq investor relations and IPO director for Asean, Hiren Krishnani, attended the ceremony. The bell ringing ceremony highlights the Company’s successful initial public offering and listing on Nasdaq. The Company began trading on Nasdaq on June 21, 2024 under the ticker symbol “RECT”. “This bell ringing ceremony marks a historic moment for all of us at Rectitude as we celebrate our successful listing on Nasdaq, one of the world’s premier equity markets,” said...

Continue reading

Kforce Inc. Announces Participation in Wells Fargo FinTech, Information and Business Services Forum

TAMPA, Fla., July 11, 2024 (GLOBE NEWSWIRE) — Kforce Inc. (NYSE: KFRC), a provider of professional staffing services and solutions, today announced that management will participate in the 9th Annual Wells Fargo FinTech, Information & Business Services Forum at the Newport Harbor Island Resort in Rhode Island on August 21, 2024. The investor presentation can be accessed at http://investor.kforce.com/ under “Events and Presentations”. About Kforce Inc. Kforce is a solutions firm specializing in technology, finance and accounting, and professional staffing services. Our KNOWLEDGEforce® empowers industry-leading companies to achieve their digital transformation goals. We curate teams of technical experts who build solutions custom-tailored to each client’s needs. These scalable, flexible outcomes are shaped by deep market knowledge,...

Continue reading

FTI Consulting to Release Second Quarter 2024 Results and Host Conference Call

WASHINGTON, July 11, 2024 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that it will release financial results for the second quarter ended June 30, 2024 before the New York market opens on Thursday, July 25, 2024. A conference call will be held to discuss these financial results on Thursday, July 25, 2024, at 9:00 a.m. Eastern Time and will be hosted by senior management. The conference call will be simulcast live on the Internet and can be accessed by logging onto the Company’s investor relations website. A replay of the webcast will be available on the Company’s investor relations website for 90 days. About FTI ConsultingFTI Consulting, Inc. is a global business advisory firm dedicated to helping organizations manage change, mitigate risk and resolve disputes: financial, legal, operational,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.